跳至主要内容
临床试验/CTRI/2020/12/029922
CTRI/2020/12/029922尚未招募未知

Preoperative prediction of residual disease in patients with advanced ovarian malignancy using HE4 and CA 125

Dr Rajlaxmi Mundhra0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • All patients of epithelial ovarian malignancy planned for primary or interval debulking surgery and those who gives consent to participate in the study.

排除标准

  • concomitant treatment for multiple types of primary cancer and decreased kidney function (glomerular filtration rate <60 mL/min/1.73 m2) since this significantly impacts the concentration of HE4.

研究者

发起方
Dr Rajlaxmi Mundhra

相似试验